MGC Pharmaceuticals launches first Derma Plus product

Company News

by Kathy Skantzos

Medical cannabis biopharma company MGC Pharmaceuticals (ASX:MXC) has launched its first Derma Plus product.

MGC’s Derma division officially launched the Herbal Repair Cream which is used to treat psoriasis.

The product is available through eCommerce platforms including the MGC Derma website, as well as existing commercial distribution channels.

The three products in the Derma Plus range were successfully tested in clinical trials during the second half of FY2017.

The other two products in the range, which are used for the relief of acne and dermatitis, will be launched during the first quarter of 2018.

Shares in MGC Pharmaceuticals (ASX:MXC) are trading 6.4 per cent lower to 9 cents.

Kathy Skantzos

Finance News Network
Kathy presents the Market Outlook and ASX company news. She joined FNN in September 2017. She has been in print and online journalism for over 9 years. She also worked in corporate communications.